Budison-FG Inhaler (5.5 mcg+10.4 mcg+182 mcg)/actuation is a triple-combination inhalation therapy containing Formoterol Fumarate, Glycopyrrolate, and Budesonide. It is primarily indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults who require triple therapy to achieve better symptom control and reduce the risk of exacerbations. By combining a long-acting bronchodilator, a long-acting muscarinic antagonist, and an inhaled corticosteroid, Budison-FG provides comprehensive management of chronic airway disease.

Formoterol Fumarate is a long-acting beta₂-adrenergic agonist (LABA) that relaxes the smooth muscles surrounding the airways, producing rapid and sustained bronchodilation for up to 12 hours. This helps relieve symptoms such as shortness of breath, wheezing, and chest tightness while improving airflow.

Glycopyrrolate is a long-acting muscarinic antagonist (LAMA) that blocks muscarinic receptors in the airway smooth muscles, preventing bronchoconstriction and promoting prolonged airway relaxation. Its addition provides further improvement in lung function and helps reduce COPD flare-ups.

Budesonide is an inhaled corticosteroid (ICS) that reduces inflammation, swelling, and mucus production in the airways. By controlling chronic airway inflammation, Budesonide helps decrease the frequency of exacerbations and supports better long-term disease control.

The combination of these three medicines addresses multiple mechanisms involved in COPD, making Budison-FG Inhaler an effective maintenance therapy for patients with persistent symptoms despite dual therapy. It improves breathing, enhances exercise tolerance, reduces hospitalizations due to exacerbations, and contributes to a better quality of life.

Budison-FG Inhaler is not intended for the relief of sudden breathing problems or acute bronchospasm. Patients should always keep a fast-acting rescue inhaler available for emergency use if prescribed by their healthcare provider.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Budison-FG Inhaler is indicated for:

• Maintenance treatment of chronic obstructive pulmonary disease (COPD)
• Reduction of moderate and severe COPD exacerbations
• Long-term management of patients requiring triple inhalation therapy
• Improvement of lung function and respiratory symptoms in COPD

How Budison-FG Inhaler Works

• Formoterol Fumarate (LABA): Relaxes airway smooth muscles to provide long-lasting bronchodilation.
• Glycopyrrolate (LAMA): Blocks muscarinic receptors, reducing bronchoconstriction and keeping the airways open.
• Budesonide (ICS): Reduces airway inflammation, swelling, and mucus production.

Together, these three medicines improve airflow, reduce inflammation, relieve respiratory symptoms, and lower the risk of COPD exacerbations.

Benefits of Budison-FG Inhaler

• Provides triple-action therapy for COPD.
• Improves breathing and lung function.
• Reduces airway inflammation.
• Offers long-lasting bronchodilation.
• Decreases the frequency of COPD exacerbations.
• Improves exercise capacity and daily activities.
• Helps enhance overall quality of life with regular use.

Dosage and Administration

Use Budison-FG Inhaler exactly as prescribed by your healthcare provider.

• Inhale the prescribed number of actuations using the correct inhaler technique.
• Use the inhaler at the same time each day for consistent symptom control.
• Rinse your mouth with water after each use and spit it out to reduce the risk of oral thrush.
• Do not exceed the prescribed dose.
• Continue treatment even if you feel well, unless advised otherwise by your physician.

This inhaler is for maintenance therapy only and should not be used to treat sudden breathing difficulties.

Possible Side Effects

Like all medicines, Budison-FG Inhaler may cause side effects, although not everyone experiences them.

Common side effects include:

• Dry mouth
• Cough
• Hoarseness
• Oral thrush (fungal infection of the mouth)
• Headache
• Tremor
• Sore throat

Less common but serious side effects may include:

• Paradoxical bronchospasm
• Fast or irregular heartbeat
• Severe allergic reactions
• Glaucoma or increased eye pressure
• Urinary retention
• Pneumonia in patients with COPD
• Low potassium levels

Seek immediate medical attention if you experience worsening breathing immediately after inhalation, chest pain, severe allergic reactions, or vision changes.

Precautions and Warnings

Before using Budison-FG Inhaler, inform your healthcare provider if you have:

• Allergy to Formoterol, Glycopyrrolate, Budesonide, or any component of the inhaler
• Heart disease or abnormal heart rhythm
• High blood pressure
• Glaucoma
• Enlarged prostate or urinary retention
• Diabetes mellitus
• Hyperthyroidism
• Tuberculosis or untreated respiratory infections
• Liver disease
• Pregnancy or breastfeeding

Regular monitoring is recommended to assess symptom control, lung function, and possible side effects during long-term treatment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

Store below 30°C in a cool, dry place away from direct sunlight and moisture. Keep the inhaler clean and replace the protective cap after use. Keep out of the reach of children.

Disclaimer

Budison-FG Inhaler is a prescription medicine intended for the maintenance treatment of COPD and should only be used under the supervision of a qualified healthcare professional. It is not a rescue inhaler and should not be used for the immediate treatment of acute bronchospasm. Always follow your healthcare provider's instructions regarding dosage and inhaler technique.